Literature DB >> 11641396

Organization of the human tarbp2 gene reveals two promoters that are repressed in an astrocytic cell line.

S Bannwarth1, L Talakoub, F Letourneur, M Duarte, D F Purcell, J Hiscott, A Gatignol.   

Abstract

TRBP1 and TRBP2 are isoforms of a double-stranded RNA-binding protein that differ in their N-terminal end and were each identified by binding to human immunodeficiency virus type 1 (HIV-1) trans-activation-responsive RNA. TRBP1 and TRBP2 also bind and modulate the function of the double-stranded RNA-activated protein kinase, protein kinase R. Both proteins increase long terminal repeat expression in human and murine cells, and their gene has been mapped to human chromosome 12. We have isolated and characterized the complete tarbp2 gene (5493 bp) coding for the two TRBP proteins. Two adjacent promoters initiate transcription of alternative first exons for TRBP1 and TRBP2 mRNAs that are spliced onto common downstream exons. TRBP2 transcription and translation start sites are localized within the first intron of TRBP1. TRBP promoters are TATA-less but have CCAAT boxes, a CpG island, and several potential binding sites for transcriptional factors. Promoter deletion analysis identified two regions from position -1397 to -330 for TRBP1 and from position -330 to +38 for TRBP2 that are important for promoter function. TRBP2 promoter activity was expressed at a higher level compared with TRBP1 promoter. In addition, a specific down-regulation of TRBP1 and TRBP2 promoter activity was identified in human astrocytic cell line U251MG compared with HeLa cells. This minimal TRBP promoter activity may account for minimal HIV-1 replication in astrocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641396     DOI: 10.1074/jbc.M104645200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR.

Authors:  Viraj R Sanghvi; Laura F Steel
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer.

Authors:  Xiaoti Lin; Minqing Wu; Peng Liu; Fengqin Wei; Laisheng Li; Hailin Tang; Xinhua Xie; Xiaoping Liu; Lu Yang; Xiaoming Xie
Journal:  Med Oncol       Date:  2014-02-22       Impact factor: 3.064

Review 3.  The role of TARBP2 in the development and progression of cancers.

Authors:  Xin Yu; Zheng Li
Journal:  Tumour Biol       Date:  2015-10-20

4.  Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response.

Authors:  Chi L Ong; Janine C Thorpe; Paul R Gorry; Sylvie Bannwarth; Anthony Jaworowski; Jane L Howard; Sean Chung; Shahan Campbell; Helen S Christensen; Guerline Clerzius; Andrew J Mouland; Anne Gatignol; Damian F J Purcell
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity?

Authors:  Anne Gatignol; Sébastien Lainé; Guerline Clerzius
Journal:  Retrovirology       Date:  2005-10-27       Impact factor: 4.602

6.  TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing.

Authors:  Astrid D Haase; Lukasz Jaskiewicz; Haidi Zhang; Sébastien Lainé; Ragna Sack; Anne Gatignol; Witold Filipowicz
Journal:  EMBO Rep       Date:  2005-10       Impact factor: 8.807

Review 7.  The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer.

Authors:  Sylvanne M Daniels; Anne Gatignol
Journal:  Microbiol Mol Biol Rev       Date:  2012-09       Impact factor: 11.056

8.  ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication.

Authors:  Guerline Clerzius; Jean-François Gélinas; Aïcha Daher; Marion Bonnet; Eliane F Meurs; Anne Gatignol
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

9.  Characterization of the TRBP domain required for dicer interaction and function in RNA interference.

Authors:  Sylvanne M Daniels; Carlos E Melendez-Peña; Robert J Scarborough; Aïcha Daher; Helen S Christensen; Mohamed El Far; Damian F J Purcell; Sébastien Lainé; Anne Gatignol
Journal:  BMC Mol Biol       Date:  2009-05-07       Impact factor: 2.946

Review 10.  Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome.

Authors:  Cheryl Bolinger; Kathleen Boris-Lawrie
Journal:  Retrovirology       Date:  2009-01-24       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.